TMD — Titan Medical Cashflow Statement
0.000.00%
Last trade - 00:00- CA$6.27m
- -CA$2.28m
- $17.63m
- 35
- 99
- 11
- 46
Annual cashflow statement for Titan Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -41.9 | -24.2 | -14.9 | -42.5 | 6.95 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | -17.4 | 28 | -12.1 | 1.97 | 1.23 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 13.3 | -4.92 | -10.4 | 12.2 | -3.68 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -46 | -0.845 | -36.6 | -27.6 | 4.68 |
| Capital Expenditures | -0.458 | -0.599 | -0.755 | -1.02 | -0.213 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | — | — | — | 0.237 |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -0.458 | -0.599 | -0.755 | -1.02 | 0.024 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 35.8 | 26.1 | 44.2 | -0.419 | -0.451 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -10.7 | 24.7 | 6.84 | -29 | 4.25 |